MY ACCOUNT | NEWSLETTER |

Management of chronic pain in the geriatric horse


"Chronic pain probably affects most, if not all, geriatric horses," says Alex Bianco, DVM, MS, Dipl. ACVIM, University of Minnesota College of Veterinary Medicine. Bianco compiled the latest research on equine pain management and shared his findings at the 2021 Veterinary Meeting & Exposition (VMX) in Orlando, Florida.

Chronic pain, despite being a common reason for euthanasia in geriatric patients, is, however, difficult to recognize for many riders. "Identifying pain should be the role of the veterinarian," says Bianco. "Research has shown how difficult it is for horse owners to do so."

Bianco commented on a 2020 Swiss study in which experienced horse owners declared that 182 horses were healthy, while veterinarians had found that 100 of them had a grade 2 of 5 or higher on the American Association of Equine scale for lameness. Practitioners (AAEP), and lameness is a characteristic component of conditions associated with chronic pain, such as osteoarthritis and laminitis. Muller et al. (2018) also noted that geriatric horses were less likely to have lameness tests compared to non-geriatric horses. Bottom line: In many cases, geriatric horse owners will not recognize a limp or request routine examinations from their veterinarian. This leaves horses at risk for undiagnosed and, therefore, uncontrolled chronic pain.

Systemic management of chronic equine pain

The study by Muller et al. also presented the reassuring fact that horse owners value their veterinarian's opinion highly. Bianco described the following options to consider when addressing chronic pain in geriatric horses systemically:

  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Cost-effective and easy to administer, they are popular for managing pain associated with arthritis and laminitis, among other chronic painful conditions. However, owners and veterinarians should consider its possible adverse effects (gastrointestinal ulceration and kidney damage) with long-term use.
  • Opioids: effective for treating multifactorial or idiopathic pain. The cost and risk of abuse of these substances in humans make their long-term use difficult.
  • Gabapentin: used in cases of neuropathic pain, but its bioavailability in horses is low. It is sometimes used as part of multimodal therapy in conjunction with other drugs.
  • Paracetamol: has analgesic effects and appears to be as effective as flunixin meglumine in treating lameness. However, due to the risks of liver toxicity, more research is needed on the efficacy and safety of this drug for equine use.
  • Ketamine: can be given as a continuous infusion together with tramadol to reduce laminitic pain. Both are controlled substances, so their handling and use should be carried out with prudence by a licensed veterinarian.

Local therapeutic options

Bianco also described some common local treatment options:

  • Intra-articular corticosteroid injections: Joint injections provide rapid relief from pain and inflammation associated with osteoarthritis. However, its use is controversial due to possible long-term harmful effects on cartilage.
  • Topical diclofenac: This NSAID can be applied on painful arthritic joints.
  • Podiatry - Therapeutic footwear is often implemented to relieve pain associated with podotrochlear syndrome or laminitis.
  • Desmotomy / Tenotomy / Neurectomy: These surgical procedures that involve the cross section of a ligament, tendon, or nerve can eradicate the source of pain.
  • Arthrodesis or facilitated ankylosis: Veterinarians generally perform surgical fusion of a joint as a last resort to add strength to the joint.

With any treatment plan, Bianco emphasized the need for frequent veterinary reevaluation in geriatric horses with chronic pain. In addition, the discussion about the "end point", which could include palliative care in advanced cases, is equally important. "Quality must be evaluated against length of life," he concluded.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

One Committed and Caring NC State Veterinary Student, So Many Choices

Like1
Dislike0

Dentalis Earns 5 VOHC® Seals, Positioning for Global Expansion in Animal Health

Like0
Dislike0

Advancing the 3Rs: innovation, implementation, ethics and society

Like0
Dislike0

Automated Knowledge-Based Radiation Treatment Planning in Canine and Feline Nasal Tumors

Like0
Dislike0

Does Lung Function Imaging Modality Have a Dosimetric Impact On Functional Avoidance Treatment Planning: Assessment Using Prospective Clinical Trial Data

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top